Latest Insider Transactions at Unitedhealth Group Inc (UNH)
This section provides a real-time view of insider transactions for Unitedhealth Group Inc (UNH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of UNITEDHEALTH GROUP INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of UNITEDHEALTH GROUP INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 19
2019
|
Timothy Patrick Flynn Director |
BUY
Grant, award, or other acquisition
|
Direct |
10
+0.35%
|
-
|
|
Mar 19
2019
|
Stephen J Hemsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
404
+0.02%
|
-
|
|
Mar 19
2019
|
Michele J Hooper Director |
BUY
Grant, award, or other acquisition
|
Direct |
106
+0.32%
|
-
|
|
Mar 19
2019
|
Frederick William Mcnabb Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
4
+0.36%
|
-
|
|
Mar 19
2019
|
Rice Valerie Md Montgomery Director |
BUY
Grant, award, or other acquisition
|
Direct |
4
+0.36%
|
-
|
|
Mar 19
2019
|
Steven H Nelson EVP & CEO, UnitedHealthcare |
BUY
Grant, award, or other acquisition
|
Direct |
60
+0.16%
|
-
|
|
Mar 19
2019
|
Glenn M Renwick Director |
BUY
Grant, award, or other acquisition
|
Direct |
156
+0.19%
|
-
|
|
Mar 19
2019
|
John F Rex President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
73
+0.09%
|
-
|
|
Mar 19
2019
|
Thomas E Roos Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
51
+0.2%
|
-
|
|
Mar 19
2019
|
Marianne D Short EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
74
+0.06%
|
-
|
|
Mar 19
2019
|
David S Wichmann Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
122
+0.01%
|
-
|
|
Mar 19
2019
|
Gail R Wilensky |
BUY
Grant, award, or other acquisition
|
Direct |
76
+0.12%
|
-
|
|
Mar 19
2019
|
D Ellen Wilson Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
68
+0.11%
|
-
|
|
Mar 19
2019
|
Andrew Witty CEO, UHG |
BUY
Grant, award, or other acquisition
|
Direct |
206
+0.34%
|
-
|
|
Mar 14
2019
|
Gail R Wilensky |
SELL
Open market or private sale
|
Direct |
2,930
-2.27%
|
$741,290
$253.43 P/Share
|
|
Mar 14
2019
|
Gail R Wilensky |
BUY
Exercise of conversion of derivative security
|
Direct |
5,860
+4.26%
|
$140,640
$24.39 P/Share
|
|
Mar 12
2019
|
Richard T Burke Director |
SELL
Open market or private sale
|
Indirect |
5,000
-0.33%
|
$1,225,000
$245.01 P/Share
|
|
Feb 26
2019
|
Stephen J Hemsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
74,494
+1.73%
|
-
|
|
Feb 26
2019
|
Stephen J Hemsley Director |
SELL
Payment of exercise price or tax liability
|
Direct |
28,766
-1.37%
|
$7,536,692
$262.98 P/Share
|
|
Feb 26
2019
|
Steven H Nelson EVP & CEO, UnitedHealthcare |
BUY
Grant, award, or other acquisition
|
Direct |
28,683
+24.47%
|
-
|
|
Feb 26
2019
|
Steven H Nelson EVP & CEO, UnitedHealthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
10,152
-24.13%
|
$2,659,824
$262.98 P/Share
|
|
Feb 26
2019
|
John F Rex President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
23,524
+12.14%
|
-
|
|
Feb 26
2019
|
John F Rex President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,300
-9.92%
|
$2,174,600
$262.98 P/Share
|
|
Feb 26
2019
|
Thomas E Roos Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,233
+11.52%
|
-
|
|
Feb 26
2019
|
Marianne D Short EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,194
+9.21%
|
-
|
|
Feb 26
2019
|
Marianne D Short EVP & Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,538
-7.94%
|
$2,498,956
$262.98 P/Share
|
|
Feb 26
2019
|
David S Wichmann Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
56,700
+3.05%
|
-
|
|
Feb 26
2019
|
David S Wichmann Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
21,910
-2.45%
|
$5,740,420
$262.98 P/Share
|
|
Feb 26
2019
|
D Ellen Wilson Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
20,081
+12.91%
|
-
|
|
Feb 26
2019
|
D Ellen Wilson Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
7,423
-11.4%
|
$1,944,826
$262.98 P/Share
|
|
Feb 26
2019
|
Andrew Witty CEO, UHG |
BUY
Grant, award, or other acquisition
|
Direct |
9,032
+13.2%
|
-
|
|
Feb 13
2019
|
Stephen J Hemsley Director |
SELL
Payment of exercise price or tax liability
|
Direct |
901
-0.04%
|
$236,963
$263.8 P/Share
|
|
Feb 13
2019
|
Steven H Nelson EVP & CEO, UnitedHealthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
675
-3.3%
|
$177,525
$263.8 P/Share
|
|
Feb 13
2019
|
John F Rex President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
688
-1.02%
|
$180,944
$263.8 P/Share
|
|
Feb 13
2019
|
Thomas E Roos Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
440
-2.0%
|
$115,720
$263.8 P/Share
|
|
Feb 13
2019
|
Marianne D Short EVP & Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
510
-0.51%
|
$134,130
$263.8 P/Share
|
|
Feb 13
2019
|
David S Wichmann Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,203
-0.14%
|
$316,389
$263.8 P/Share
|
|
Feb 13
2019
|
D Ellen Wilson Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
447
-0.91%
|
$117,561
$263.8 P/Share
|
|
Feb 08
2019
|
Stephen J Hemsley Director |
SELL
Payment of exercise price or tax liability
|
Direct |
6,200
-0.1%
|
$1,618,200
$261.9 P/Share
|
|
Feb 08
2019
|
Steven H Nelson EVP & CEO, UnitedHealthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
1,816
-2.79%
|
$473,976
$261.9 P/Share
|
|
Feb 08
2019
|
John F Rex President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,403
-1.16%
|
$627,183
$261.9 P/Share
|
|
Feb 08
2019
|
Thomas E Roos Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,475
-3.19%
|
$384,975
$261.9 P/Share
|
|
Feb 08
2019
|
Marianne D Short EVP & Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,789
-0.59%
|
$466,929
$261.9 P/Share
|
|
Feb 08
2019
|
David S Wichmann Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,081
-0.2%
|
$1,326,141
$261.9 P/Share
|
|
Feb 08
2019
|
D Ellen Wilson Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,873
-1.24%
|
$488,853
$261.9 P/Share
|
|
Feb 01
2019
|
David S Wichmann Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
61,985
-6.75%
|
$16,735,950
$270.2 P/Share
|
|
Feb 01
2019
|
David S Wichmann Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
113,122
+10.97%
|
$3,280,538
$29.74 P/Share
|
|
Jan 23
2019
|
Richard T Burke Director |
SELL
Open market or private sale
|
Direct |
11,500
-5.93%
|
$3,082,000
$268.0 P/Share
|
|
Jan 22
2019
|
William C Ballard Jr Director |
SELL
Open market or private sale
|
Direct |
5,000
-6.43%
|
$1,330,000
$266.61 P/Share
|
|
Jan 22
2019
|
William C Ballard Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+6.05%
|
$100,000
$20.68 P/Share
|